Keywords: india, lax, patent, regime, hits, pharmaceutical, companies

India's Lax Patent Regime Hits US Pharmaceutical Companies

Article | 07 January 1998

Print This

The Pharmaceutical Research and Manufacturers of America has told theUS government that it is losing sales worth $500 million every year ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in